Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease

被引:19
作者
Abbiss, Hayley [1 ,3 ,4 ]
Maker, Garth L. [4 ,5 ]
Gummer, Joel [3 ]
Sharman, Matthew J. [2 ]
Phillips, Jacqueline K. [6 ]
Boyce, Mary [1 ]
Trengove, Robert D. [3 ,5 ]
机构
[1] Edith Cowan Univ, Sch Nat Sci, Perth, WA, Australia
[2] Edith Cowan Univ, Sch Exercise & Hlth Sci, Perth, WA, Australia
[3] Murdoch Univ, Separat Sci & Metabol Lab, Perth, WA, Australia
[4] Murdoch Univ, Sch Vet & Biomed Sci, Perth, WA, Australia
[5] Murdoch Univ Node, Metabol Australia, Perth, WA, Australia
[6] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia
关键词
biomarker; gas chromatography; metabolite; polycystic kidney disease; urine; BIOLOGICAL SAMPLES; EXPRESSION; CHALLENGES;
D O I
10.1111/j.1440-1797.2011.01532.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: The purpose of this research was to use metabolomics to investigate the cystic phenotype in the Lewis polycystic kidney rat. Methods: Spot urine samples were collected from four male Lewis control and five male Lewis polycystic kidney rats aged 5 weeks, before kidney function was significantly impaired. Metabolites were extracted from urine and analysed using gas chromatography-mass spectrometry. Principal component analysis was used to determine key metabolites contributing to the variance observed between sample groups. Results: With the development of a metabolomics method to analyse Lewis and Lewis polycystic kidney rat urine, 2-ketoglutaric acid, allantoin, uric acid and hippuric acid were identified as potential biomarkers of cystic disease in the rat model. Conclusion: The findings of this study demonstrate the potential of metabolomics to further investigate kidney disease.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 34 条
[1]   Extraction and GC/MS analysis of the human blood plasma metabolome [J].
A, J ;
Trygg, J ;
Gullberg, J ;
Johansson, AI ;
Jonsson, P ;
Antti, H ;
Marklund, SL ;
Moritz, T .
ANALYTICAL CHEMISTRY, 2005, 77 (24) :8086-8094
[2]   1H NMR-based metabonomic analysis of urine from young spontaneously hypertensive rats [J].
Akira, Kazuki ;
Masu, Shigenori ;
Imachi, Misako ;
Mitome, Hidemichi ;
Hashimoto, Miho ;
Hashimoto, Takao .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 46 (03) :550-556
[3]   Determination of allantoin in biofluids using micellar electrokinetic capillary chromatography [J].
Alfazema, LN ;
Howells, S ;
Perrett, D .
JOURNAL OF CHROMATOGRAPHY A, 1998, 817 (1-2) :345-352
[4]   Metabolomics analysis II. Preparation of biological samples prior to detection [J].
Alvarez-Sanchez, B. ;
Priego-Capote, F. ;
Luque de Castro, M. D. .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2010, 29 (02) :120-127
[5]   Metabolomics analysis I. Selection of biological samples and practical aspects preceding sample preparation [J].
Alvarez-Sanchez, B. ;
Priego-Capote, F. ;
Luque de Castro, M. D. .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2010, 29 (02) :111-119
[6]   Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies [J].
Bando, Kiyoko ;
Kawahara, Rui ;
Kunimatsu, Takeshi ;
Sakai, Jun ;
Kimura, Juki ;
Funabashi, Hitoshi ;
Seki, Takaki ;
Bamba, Takeshi ;
Fukusaki, Eiichiro .
JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2010, 110 (04) :491-499
[7]   Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine [J].
Bukanov, Nikolay O. ;
Smith, Laurie A. ;
Klinger, Katherine W. ;
Ledbetter, Steven R. ;
Ibraghimov-Beskrovnaya, Oxana .
NATURE, 2006, 444 (7121) :949-952
[8]   Challenges and developments in tandem mass spectrometry based clinical metabolomics [J].
Ceglarek, Uta ;
Leichtle, Alexander ;
Bruegel, Mathias ;
Kortz, Linda ;
Brauer, Romy ;
Bresler, Kristin ;
Thiery, Joachim ;
Fiedler, Georg Martin .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) :266-271
[9]   Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats [J].
Deguchi, T ;
Takemoto, M ;
Uehara, N ;
Lindup, WE ;
Suenaga, A ;
Otagiri, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (02) :932-938
[10]   Oxidative stress as a major culprit in kidney disease in diabetes [J].
Forbes, Josephine M. ;
Coughlan, Melinda T. ;
Cooper, Mark E. .
DIABETES, 2008, 57 (06) :1446-1454